Sterling Biotech Limited manufactures and sells pharma grade gelatin and di-calcium phosphate, and other pharma products in India and internationally. The company provides Simvastatin ammonium salt and Lovastatin, a fermentation active pharmaceutical ingredient (API) products used in cardiovascular therapy. It also offers Daunorubicin HCL, Doxorubicin HCL, Epirubicin HCL, and Idarubicin HCL products, which are used in oncology therapies; and Zoledronic Acid, a synthetic active pharmaceutical ingredient generic product. The company was incorporated in 1985 and is based in Vadodara, India along with branch in Mumbai, India. As of August 29, 2024, Sterling Biotech Limited operates as a subsidiary of Zydus Animal Health and Investments Limited.
Metrics to compare | STBI | Peers Peers - average of corresponding metrics from companies closely matching STBI: | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSTBIPeersSector |
---|---|---|---|---|
P/E Ratio | 0.0x | 0.0x | 0.0x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.0x | 0.0x | 0.0x | |
Price / LTM Sales | 0.0x | 0.0x | 0.0x | |
Upside (Analyst Target) | 0.0% | 0.0% | 0.0% | |
Fair Value Upside | Unlock | 0.0% | 0.0% | Unlock |